SPDR® S&P Biotech ETF (XBI)

89.21
Delayed Data
As of 4:10pm ET
 -1.53 / -1.69%
Today’s Change
66.66
Today|||52-Week Range
97.98
+5.11%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-2.88% 3 years+6.08%
3 months+3.41% 5 years+22.53%
1 year+34.36% Since inception+15.39%
Data through 04/19/2018

Quote Details

Previous close$90.74
Open day’s range88.93 – 91.12
Net asset value (NAV)90.85 (04/18/2018)
Daily volume5,723,731
Average volume (3 months)4,843,529
Data as of 4:10pm ET, 04/19/2018

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+22.53%+14.29%
Expense Gross exp ratio0.35%1.30%
Risk 5 year sharpe ratio0.790.92
Net assets$4.9B$3.0B
Average market cap$3.2B$10.0B
Average P/E--22.2
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ONCE Spark Therapeutics Inc1.63%
RDUS Radius Health Inc1.53%
REGN Regeneron Pharmaceuticals1.52%
FOLD Amicus Therapeutics Inc1.52%
SRPT Sarepta Therapeutics Inc1.50%
ALKS Alkermes Plc1.49%
AGIO Agios Pharmaceuticals Inc1.47%
UTHR United Therapeutics Corp1.47%
BMRN Biomarin Pharmaceutical Inc1.46%
CELG Celgene1.45%